miR-584-5p是一种新的潜在预后生物标志物,用于头部和部状细胞癌

Donghong Yang1, Guanbin Huang1, Haiwen Li1

  • 1Department of Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, Guangdong, China.

概括

微RNA-584-5p (miR-584-5p) 在头部和部状细胞癌 (HNSC) 中是上调调的,与较差的生存结果相关. 这种微RNA显示出作为HNSC患者治疗标和预后生物标记物的潜力.